0001811122-20-000001.txt : 20200505 0001811122-20-000001.hdr.sgml : 20200505 20200504175412 ACCESSION NUMBER: 0001811122-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200504 EFFECTIVENESS DATE: 20200505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elgia Therapeutics, Inc. CENTRAL INDEX KEY: 0001811122 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366256 FILM NUMBER: 20846141 BUSINESS ADDRESS: STREET 1: 10686 HUNTERS GLEN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-336-0916 MAIL ADDRESS: STREET 1: 10686 HUNTERS GLEN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001811122 Elgia Therapeutics, Inc. 10686 HUNTERS GLEN DRIVE SAN DIEGO CA CALIFORNIA 92130 858-336-0916 DELAWARE None None Corporation true 2019 Alan Saltiel c/o Elgia Therapeutics, Inc. 10686 Hunters Glen Drive San Diego CA CALIFORNIA 92130 Executive Officer Director Ariel Feldstein c/o Elgia Therapeutics, Inc. 10686 Hunters Glen Drive San Diego CA CALIFORNIA 92130 Executive Officer Director Brian Hubbard c/o Elgia Therapeutics, Inc. 10686 Hunters Glen Drive San Diego CA CALIFORNIA 92130 Director Thomas Coll c/o Elgia Therapeutics, Inc. 10686 Hunters Glen Drive San Diego CA CALIFORNIA 92130 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-04-28 false true false 0 10000000 2330002 7669998 false 2 0 0 0 false Elgia Therapeutics, Inc. Alan Saltiel Alan Saltiel Chief Executive Officer 2020-05-04